10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -148,785 | -106,871 | -42,413 | -58,223 | -39,774 |
| Depreciation Amortization | 24,534 | 16,419 | 8,158 | 28,254 | 20,930 |
| Accounts receivable | 1,673 | 9,025 | 8,728 | -34,041 | -27,216 |
| Accounts payable and accrued liabilities | 6,082 | 10,262 | 2,875 | 11,084 | 12,191 |
| Other Working Capital | -20,072 | -10,133 | -12,594 | -88,490 | -77,458 |
| Other Operating Activity | 89,239 | 43,533 | 14,444 | 120,043 | 84,149 |
| Operating Cash Flow | $-47,329 | $-37,765 | $-20,802 | $-21,373 | $-27,178 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -224,288 | -229,730 | -229,422 | N/A | N/A |
| PPE Investments | -91,927 | -55,355 | -28,136 | -101,278 | -73,660 |
| Net Acquisitions | -1,500 | N/A | N/A | -5,451 | -5,451 |
| Investing Cash Flow | $-317,715 | $-285,085 | $-257,558 | $-106,729 | $-79,111 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -5,409 | -5,409 | -5,409 | -5,028 | -5,028 |
| Common Stock Issued | 16,225 | 14,186 | 7,826 | 40,325 | 31,422 |
| Financing Cash Flow | $10,816 | $8,777 | $2,417 | $35,297 | $26,394 |
| Exchange Rate Effect | -295 | -210 | -18 | 234 | 316 |
| Beginning Cash Position | 596,073 | 596,073 | 596,073 | 688,644 | 688,644 |
| End Cash Position | 241,550 | 281,790 | 320,112 | 596,073 | 609,065 |
| Net Cash Flow | $-354,523 | $-314,283 | $-275,961 | $-92,571 | $-79,579 |
| Free Cash Flow | |||||
| Operating Cash Flow | -47,329 | -37,765 | -20,802 | -21,373 | -27,178 |
| Capital Expenditure | -91,927 | -55,355 | -28,136 | -101,278 | -73,660 |
| Free Cash Flow | -139,256 | -93,120 | -48,938 | -122,651 | -100,838 |